
Elder Bio Drugs Private Limited
About Elder Bio Drugs Private Limited
Data last updated:
Elder Bio Drugs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 21 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24110MP2020PTC053817. Its GSTIN is 23AAGCE2098D1ZW (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Elder Lifesciences Private Limited. It is led by directors Akhil Pahuja and Aman Pahuja.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.03 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.98 Lakh (net margin 1%) and EBITDA of ₹2.78 Lakh (EBITDA margin 1.4%).
Company details
Contact details
Elder Bio Drugs Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address37 – A Mangal Compound, Pipliya Kumar, Indore, Madhya Pradesh, India – 452010
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Elder Bio Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elder Bio Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elder Bio Drugs Private Limited, buy the company report.
Financials of Elder Bio Drugs Private Limited
FY 2025 filings availableElder Bio Drugs Private Limited reported revenue of ₹2.03 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.98 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elder Bio Drugs Private Limited, buy the company report.
Board of directors of Elder Bio Drugs Private Limited
Elder Bio Drugs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akhil Pahuja Also directs: Hoechst Life Care Private Limited | Director | 21 Nov 2020 | 6 Years 0 Months | Current |
| Aman Pahuja Also directs: Hoechst Life Care Private Limited | Director | 21 Nov 2020 | 6 Years 0 Months | Current |
Peer comparison
Elder Bio Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reown Hygn Private Limited | ₹2.04 Cr (FY 2025) | 66.0% | Thane, Maharashtra, India | |||
| Succor Health Care Private Limited | ₹2.04 Cr (FY 2023) | -22.0% | Kalady, Kerala, India | |||
| Elder Bio Drugs Private Limitedthis company | ₹2.03 Cr (FY 2025) | ₹1.98 Lakh | 1% | 6.0% | Indore, Madhya Pradesh, India | |
| Medsea Healthcare Private Limited | ₹2.03 Cr (FY 2024) | -13.0% | New Delhi, Delhi, India | |||
| Vishnu Medical Agencies Pvt Ltd | ₹2.03 Cr (FY 2024) | 7.0% | Gwalior, Madhya Pradesh, India |
To see the full peer comparison of Elder Bio Drugs Private Limited, buy the company report.
Auditor
Elder Bio Drugs Private Limited is audited by SANDEEP SURENDRA JAIN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANDEEP SURENDRA JAIN & CO. | FY 2023 | 010172C |
Shareholding
The shareholding of Elder Bio Drugs Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Elder Bio Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elder Bio Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elder Bio Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elder Bio Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAGCE2098D1ZW | Madhya Pradesh | Active | 01 Sep 2021 |
To see the full GST registrations and return filing status of Elder Bio Drugs Private Limited, buy the company report.
Recent activity
Elder Bio Drugs Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Akhil Pahuja was appointed as Director on 21 Nov 2020.
Frequently asked questions
Elder Bio Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in wholesale, within the trading industry. It was incorporated on 21 November 2020 (6+ years old) and is registered under CIN U24110MP2020PTC053817.
Elder Bio Drugs has 2 current directors:
- Akhil Pahuja - Director
- Aman Pahuja - Director
The latest financial statements of Elder Bio Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Elder Bio Drugs is 23AAGCE2098D1ZW, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Elder Bio Drugs is U24110MP2020PTC053817. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elder Bio Drugs was incorporated on 21 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Elder Bio Drugs by revenue are Reown Hygn Private Limited, Succor Health Care Private Limited, Medsea Healthcare Private Limited, Vishnu Medical Agencies Pvt Ltd, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Akhil Pahuja was appointed as Director on 21 Nov 2020. Aman Pahuja was appointed as Director on 21 Nov 2020.
The registered office of Elder Bio Drugs is at 37 – A Mangal Compound, Pipliya Kumar, Indore, Madhya Pradesh, India – 452010.
Elder Bio Drugs operates in the trading industry, in the wholesale segment.
Yes. Elder Bio Drugs was formerly known as Elder Lifesciences Private Limited.

